Quellen & Studien
1. DHL - Deutsche Hochdruckliga e.V., Deutsche Gesellschaft für Hypertonie und Prävention. (2015). Bluthochdruck wirksam bekämpfen.
2. Schwabe, U., Paffrath, D. (2015). Arzneiverordnungsreport 2015. Springer-Verlag, Berlin Heidelberg.
3. Lebensmittellexikon.de (2016). Natriumnitrat, E 251, Natronsalpeter, Salpetersaures Natrium, Chilesalpeter.
4. Lebensmittellexikon.de (2016). Natriumnitrit, E 250.
5. Bunyan, J., Murrell, EA., Shah, PP. (1976) . The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 35(1): 25-39.
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005). Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–23.
7. Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H., Hayek, T. (2004). Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23(3): 423-33.
8. Asgary, S., Keshvari, M., Sahebkar, A., Hashemi, M., Rafieian-Kopaei, M. (2013). Clinical investigation of the acute effects of pomegranate juice on blood pressure and endothelial function in hypertensive individuals. ARYA Atheroscler 9(6): 326-331.
9. Actis-Goretta, L., Ottaviani, JI., Keen, CL., Fraga, CG. (2003). Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 555(3): 597-600.
10. Liu, Y., Ma, W., Zhang, P., He, S., Huang, D. (2015). Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr 34(1): 27-34.
11. Ferrieres, J. (2004). The French paradox: lessons for other countries. Heart 90(1): 107-111.
12. Gopa, B., Bhatt, J., Hemavathi, KG. (2012). A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol 44(2): 238-242.
13. Zapfe, G. (2001). Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 8(4): 262-6.
14. Asgary, S., Naderi, GH., Sadeghi, M., Kelishadi, R., Amiri, M. (2004). Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res 30(5-6):221-225.
15. Asgary, S., Naderi, GH., Sadeghi, M., Kelishadi, R., Amiri, M. (2004). Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res 30(5-6):221-225.
16. Veveris, M., Koch, E., Chatterjee, SS. (2004).Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia at reperfusion. Life Sci 74: 1945–1955.
17. Koulivand, PH., Ghadiri, MK., Gorji, A. (2013). Lavender and the Nervous System. Evid Bases Complement Alternat Med 2013: 681304.
18. Mancilha-Carvalho, JJ., Souza e Silva, NA. (2003). The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol 80(3): 289-300.
19. Mancilha-Carvalho JJ, Carvalho JV, Lima JA, Sousa e Silva NA. (1992). [The absence of risk factors for coronary disease in Yanomami Indians and the influence of acculturation on arterial pressure].Arq Bras Cardiol. 1992 Oct;59(4):275-83.
20. Rosenfeldt, FL., Haas, SJ., Krum, H., Hadj, A., Ng, K., Leong, JY., Watts, GF. (2007). Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 21(4): 297-306.
21. Yamagami, T., Kagami, H., et al. Effect of coenzyme Q10 on essential hypertension, a double-blind controlled study. In: Folkers, K., Yamamura, Y. (1986). Biomedical and Clinical Aspects of Coenzyme Q10: Proceedings of the Fifth International Symposium on the Biomedical and Clinical Aspects of Coenzyme Q10. Elsevier Science Publishers 5: 337–343.
22. Dong, JY., Qin, LQ., Zhang, Z., Zhao, Y., Wang, J., Arigoni, F., Zhang, W. (2011). Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J 162(6): 959-65.
23. Sukhovershin, RA., Yepuri, G., Ghebremariam, YT. (2015). Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy. Methodist Debakey Cardiovasc J 11(3): 166-171.
24. Monti, LD., Setola, E., Lucotti, PC., Marrocco-Trischitta, MM., Comola, M., Galluccio, E., Poggi, A., Mammi, S., Catapano, AL., Comi, G., Chiesa, R., Bosi, E., Piatti, PM. (2012). Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 14(10): 893-900.
25. Bolland, MJ., Avenell, A., Baron, JA., Grey, A., MacLennan, GS., Gamble, GD., Reid, IR. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341: 3691.glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 14(10): 893-900.
26. Pfeifer, M., Begerow, B., Minne, HW., Nachtigall, D., Hansen, C. (2001). effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol metab 86(4): 1633-7.
27. Chai, W., Cooney, RV., Franke, AA., Bostick, RM. (2013). Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 23(9): 564-70.
28. Shea, MK., Holden, RM. (2012). Vitamin K Status and Vascular Calcification: Evidence from Observational and Clinical Studies. Adv Nutr 3(2): 158-165.
29. Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, MM., Hedayati, M., Rashidkhani, B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci 17(12): 1161-1169.
30. Statista. (2016). Anteil der Herzinfarktpatienten mit Bluthochdruck nach Geschlecht im Vergleich der jahre 1987 und 2008.